Literature DB >> 35230210

Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease.

Ryuhei Kondo1, Jennifer Austin2, Mary Akel3, Vineet M Arora3, Valerie G Press3.   

Abstract

CONCLUSIONS: Models representing transitions from all-nebulized to nebulizer-plus-MDI respiratory medications resulted in cost savings, largely from the reduction of labor cost of nebulizer administration with nebs-only treatment. Therefore, transitioning from nebs to MDIs can lead to cost savings and could allow greater opportunities for inhaler education.

Entities:  

Keywords:  COPD; High-value care; asthma; metered dose inhalers; patient education; self-management

Year:  2022        PMID： 35230210      PMCID： PMC9549903          DOI： 10.1080/02770903.2022.2047718

Source DB:  PubMed          Journal:  J Asthma        ISSN： 0277-0903


  21 in total

1.  "Nebs no more after 24": a pilot program to improve the use of appropriate respiratory therapies.

Authors:  Christopher Moriates; Maria Novelero; Kathryn Quinn; Raman Khanna; Michelle Mourad
Journal:  JAMA Intern Med       Date:  2013-09-23       Impact factor: 21.873

2.  Critical analysis of common canister programs: a review of cross-functional considerations and health system economics.

Authors:  Trent Larson; Ravindra Gudavalli; Dean Prater; Scott Sutton
Journal:  Curr Med Res Opin       Date:  2015-03-19       Impact factor: 2.580

3.  Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Authors:  David B Price; Miguel Román-Rodríguez; R Brett McQueen; Sinthia Bosnic-Anticevich; Victoria Carter; Kevin Gruffydd-Jones; John Haughney; Svein Henrichsen; Catherine Hutton; Antonio Infantino; Federico Lavorini; Lisa M Law; Karin Lisspers; Alberto Papi; Dermot Ryan; Björn Ställberg; Thys van der Molen; Henry Chrystyn
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-09

4.  Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.

Authors:  Andrew P Yu; Annie Guérin; Diego Ponce de Leon; Karthik Ramakrishnan; Eric Q Wu; Michelle Mocarski; Steven I Blum; Juliana Setyawan
Journal:  Respir Med       Date:  2011-07-31       Impact factor: 3.415

5.  Misuse of respiratory inhalers in hospitalized patients with asthma or COPD.

Authors:  Valerie G Press; Vineet M Arora; Lisa M Shah; Stephanie L Lewis; Krystal Ivy; Jeffery Charbeneau; Sameer Badlani; Edward Nareckas; Edward Naurekas; Antoinette Mazurek; Jerry A Krishnan
Journal:  J Gen Intern Med       Date:  2011-01-20       Impact factor: 5.128

6.  The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.

Authors:  Sinthia Bosnic-Anticevich; Henry Chrystyn; Richard W Costello; Myrna B Dolovich; Monica J Fletcher; Federico Lavorini; Roberto Rodríguez-Roisin; Dermot Ryan; Simon Wan Yau Ming; David B Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-21

Review 7.  The use of nebulized pharmacotherapies during the COVID-19 pandemic.

Authors:  Sanjay Sethi; Igor Z Barjaktarevic; Donald P Tashkin
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

8.  Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.

Authors:  Valerie G Press; Andrea S Gershon; Frank C Sciurba; Denitza P Blagev
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

9.  Effectiveness of Virtual vs In-Person Inhaler Education for Hospitalized Patients With Obstructive Lung Disease: A Randomized Clinical Trial.

Authors:  Valerie G Press; Vineet M Arora; Colleen A Kelly; Kyle A Carey; Steve R White; Wen Wan
Journal:  JAMA Netw Open       Date:  2020-01-03

Review 10.  Guidance on nebulization during the current COVID-19 pandemic.

Authors:  Mario Cazzola; Josuel Ora; Andrea Bianco; Paola Rogliani; Maria Gabriella Matera
Journal:  Respir Med       Date:  2020-11-19       Impact factor: 3.415
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.